metaLead Therapeutics AG

Next-generation medications to treat metal-related diseases.

Swiss Startup - metaLead Therapeutics Main Image

Swiss Startup - metaLead Therapeutics Team Image

metaLead is pioneering the development of novel drugs to treat metal-related diseases such as Wilson disease and lead poisoning. Our platform technology is based on a class of short peptides designed to tightly and selectively bind to metal ions of interest and expel them effectively and safely.
metaLead is currently focusing on Wilson disease, a rare genetic disorder causing the accumulation of copper in the liver and the brain in toxic amounts.
metaLead's drug peptides are superior to the standards of care in these disease areas thanks to unique characteristics that enable complete control of their biochemical features and mechanism of action.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.

31.10.2025

More than 20 Swiss biotech companies to exhibit at Bio Europe (startupticker.ch)

15.10.2025

Industry veterans join Lifesciences and fashion-tech startups (startupticker.ch)

06.05.2025

MetaLead Secures CHF 1M to advance treatment for Wilson's disease (venturelab.swiss)

06.05.2025

metaLead secures CHF 1 million to tackle metal poisoning (startupticker.ch)

06.12.2024

BaseLaunch supports the development of therapies for metal- and age-related diseases (startupticker.ch)

05.11.2024

Bio Europe in Stockholm hosts 33 Swiss companies (startupticker.ch)

29.12.2023

Recognition for the novel solutions (startupticker.ch)

04.07.2023

Venture Leaders Biotech 2023: Captain’s Blog by Navignostics, Mosanna Therapeutics, Limula, and Tandem Therapeutics (venturelab.swiss)

19.06.2023

The Venture Leaders Biotech set sail on the Boston roadshow with immersive expert workshops, uniting entrepreneurs and investors in the US market (venturelab.swiss)

02.05.2023

metaLead: The Venture Leader Biotech striving to eradicate toxic metal poisoning (venturelab.swiss)

25.04.2023

Venture Leaders Biotech kick off their Boston roadshow at Swiss Biotech Day (venturelab.swiss)

19.04.2023

Swiss National Startup Team 2023: 10 biotech innovators are headed to Boston (venturelab.swiss)

10.03.2023

metaLead Therapeutics wins CHF 150,000 to develop next-gen antidotes against toxic metals (venturekick.ch)

06.05.2025

metaLead receives CHF 1 M investment from the UZH LSF.

01.04.2025

metaLead validates its PoC in Wilson disease after pivoting from lead poisoning.

18.08.2024

metaLead joins BaseLaunch's portfolio.

01.09.2023

metaLead got accepted to the BioInnovation Institute Venture Lab program

12.04.2023

metaLead is within the Top 10 in the "Health and Nutrition" vertical of the >>venture>> competition

01.03.2023

Michal receives the UZH Biotech Entrepreneurship Fellowship

01.03.2023

metaLead receives support from Innosuisse Project

15.02.2023

metaLead successfully passes the third and final stage of Venture Kick

No Jobs

No videos and documents

TOP 100 Swiss Startup Award

The TOP 100 Swiss Startup Ranking features the 100 most promising startups that are not older than five years and are selected by a jury of early-stage investors.

TOP 100 Swiss Startups 2025

Website

Venture Kick

Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.

Venture Kick (150'000) 2023

Website